Avant Brands Inc. (TSX:AVNT)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Market Capitalization	8	6	36	40	56	19
Market Cap Growth	-55.61%	-83.91%	-9.74%	-28.09%	188.63%	-30.52%
Enterprise Value	22	18	54	40	40	26
Last Close Price	0.72	0.55	4.20	5.85	8.40	4.20
PS Ratio	0.22	0.16	1.38	2.00	5.88	2.45
PB Ratio	0.28	0.18	0.74	0.83	1.17	0.68
P/TBV Ratio	0.29	0.19	0.88	1.18	1.26	1.01
P/FCF Ratio	13.15	14.56	19.55	-	-	-
P/OCF Ratio	11.77	11.51	6.70	-	-	-
EV/Sales Ratio	0.61	0.50	2.05	1.97	4.24	3.25
EV/EBITDA Ratio	-	-	-	-	-	68.23
EV/FCF Ratio	36.30	44.84	29.05	-	-	-
Debt / Equity Ratio	0.56	0.54	0.38	0.06	0.01	0.26
Debt / EBITDA Ratio	-	-	25.62	-	-	10.68
Debt / FCF Ratio	26.45	44.36	10.08	-	-	-
Asset Turnover	0.58	0.50	0.35	0.34	0.21	0.18
Inventory Turnover	2.64	2.41	0.87	1.87	1.36	0.59
Quick Ratio	0.53	0.63	0.28	3.59	7.03	0.46
Current Ratio	1.68	1.75	1.66	8.35	10.93	1.78
Return on Equity (ROE)	-56.43%	-54.89%	-10.61%	-13.77%	-29.18%	-30.06%
Return on Assets (ROA)	-11.23%	-12.45%	-1.21%	-9.08%	-7.53%	-0.01%
Return on Capital (ROIC)	-13.49%	-14.90%	-1.52%	-10.70%	-8.15%	-0.02%
Earnings Yield	-261.59%	-386.38%	-13.98%	-18.77%	-20.10%	-52.53%
FCF Yield	7.60%	6.87%	5.11%	-12.20%	-11.12%	-8.88%
Buyback Yield / Dilution	-21.39%	-17.57%	-24.55%	-10.52%	-35.25%	-33.79%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.